+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Tumor Diagnosis and Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

  • ID: 4719801
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 4

FEATURED COMPANIES

  • AstraZeneca
  • Carestream Health
  • GE Healthcare
  • Hitachi Medical Systems
  • Merck & Co., Inc
  • Pfizer,Inc
  • MORE
The report on the global brain tumor diagnosis and treatment market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global brain tumor diagnosis and treatment market to grow with a CAGR of 8.7% over the forecast period from 2018-2024. The study on brain tumor diagnosis and treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on brain tumor diagnosis and treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global brain tumor diagnosis and treatment market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global brain tumor diagnosis and treatment market over the period of 2016 to 2024. Further, the Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers
  • Growing Prevalence of Neurological Disorder
  • Rising Geriatric Population over the Globe
2. Restraints
  • High Cost Related to Brain Tumor Diagnosis and Treatments
3. Opportunities
  • Development in Technologically Advanced Product
Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global brain tumor diagnosis and treatment market is segmented on the basis of diagnosis type, treatment type, and product type.

The Global Brain Tumor Diagnosis and Treatment Market by Diagnosis Type
  • MRI
  • CT Scan
  • PET-CT Scan
  • EEG
  • Molecular Testing
  • Others
The Global Brain Tumor Diagnosis and Treatment Market by Treatment Type
  • Surgery
  • Radiation Therapy
  • Radiosurgery
  • Chemotherapy
  • Targeted Drug Therapy
  • Immunotherapy
The Global Brain Tumor Diagnosis and Treatment Market by Product Type
  • Primary Brain Tumor
  • Secondary Brain Tumor
Company Profiles

The companies covered in the report include:
  • GE Healthcare
  • Merck & Co., Inc
  • AstraZeneca
  • Carestream Health
  • Philips Healthcare
  • Siemens Healthcare Private Limited
  • Shimadzu Corporation
  • Hitachi Medical Systems
  • Pfizer,Inc
  • Toshiba Medical Systems
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the brain tumor diagnosis and treatment market.

2. Complete coverage of all the segments in the brain tumor diagnosis and treatment market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in the global brain tumor diagnosis and treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca
  • Carestream Health
  • GE Healthcare
  • Hitachi Medical Systems
  • Merck & Co., Inc
  • Pfizer,Inc
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Brain Tumor Diagnosis and Treatment Market Highlights
2.2. Brain Tumor Diagnosis and Treatment Market Projection
2.3. Brain Tumor Diagnosis and Treatment Market Regional Highlights

3. Global Brain Tumor Diagnosis and Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Diagnosis Type
3.4.2. Growth Matrix Analysis by Treatment Type
3.4.3. Growth Matrix Analysis by Product Type
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Brain Tumor Diagnosis and Treatment Market

4. Brain Tumor Diagnosis and Treatment Market Macro Indicator Analysis

5. Global Brain Tumor Diagnosis and Treatment Market by Diagnosis Type
5.1. MRI
5.2. CT Scan
5.3. PET-CT Scan
5.4. EEG
5.5. Molecular Testing
5.6. Others

6. Global Brain Tumor Diagnosis and Treatment Market by Treatment Type
6.1. Surgery
6.2. Radiation Therapy
6.3. Radiosurgery
6.4. Chemotherapy
6.5. Targeted Drug Therapy
6.6. Immunotherapy

7. Global Brain Tumor Diagnosis and Treatment Market by Product Type
7.1. Primary Brain Tumor
7.2. Secondary Brain Tumor

8. Global Brain Tumor Diagnosis and Treatment Market by Region 2018-2024
8.1. North America
8.1.1. North America Brain Tumor Diagnosis and Treatment Market by Diagnosis Type
8.1.2. North America Brain Tumor Diagnosis and Treatment Market by Treatment Type
8.1.3. North America Brain Tumor Diagnosis and Treatment Market by Product Type
8.1.4. North America Brain Tumor Diagnosis and Treatment Market by Country
8.2. Europe
8.2.1. Europe Brain Tumor Diagnosis and Treatment Market by Diagnosis Type
8.2.2. Europe Brain Tumor Diagnosis and Treatment Market by Treatment Type
8.2.3. Europe Brain Tumor Diagnosis and Treatment Market by Product Type
8.2.4. Europe Brain Tumor Diagnosis and Treatment Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Brain Tumor Diagnosis and Treatment Market by Diagnosis Type
8.3.2. Asia-Pacific Brain Tumor Diagnosis and Treatment Market by Treatment Type
8.3.3. Asia-Pacific Brain Tumor Diagnosis and Treatment Market by Product Type
8.3.4. Asia-Pacific Brain Tumor Diagnosis and Treatment Market by Country
8.4. RoW
8.4.1. RoW Brain Tumor Diagnosis and Treatment Market by Diagnosis Type
8.4.2. RoW Brain Tumor Diagnosis and Treatment Market by Treatment Type
8.4.3. RoW Brain Tumor Diagnosis and Treatment Market by Product Type
8.4.4. RoW Brain Tumor Diagnosis and Treatment Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Brain Tumor Diagnosis and Treatment Market
9.2. Companies Profiles
9.2.1. GE Healthcare
9.2.2. Merck & Co., Inc
9.2.3. AstraZeneca
9.2.4. Carestream Health
9.2.5. Philips Healthcare
9.2.6. Siemens Healthcare Private Limited
9.2.7. Shimadzu Corporation
9.2.8. Hitachi Medical Systems
9.2.9. Pfizer,Inc
9.2.10. Toshiba Medical Systems

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GE Healthcare
  • Merck & Co., Inc
  • AstraZeneca
  • Carestream Health
  • Philips Healthcare
  • Siemens Healthcare Private Limited
  • Shimadzu Corporation
  • Hitachi Medical Systems
  • Pfizer,Inc
  • Toshiba Medical Systems
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4719801
Adroll
adroll